Abstract
Radiolabeled oligodeoxynucleotides (ODNs) have the potential of having
both direct antisense inhibition and radiation effects being derived against the most
specific target, a DNA/RNA sequence. Nuclear DNA is the primary target for ionizing
radiation, and low-energy electrons with short ranges are responsible for the
radiotoxicity of Auger electron emitters. Antisense technology has begun to provide an
alternative approach for manipulating the expression of specific genes. Here, we
optimize the label of ODNs with Auger-emitting radionuclides by calculating
subcellular dose distribution. We show that for subcellular targeting, internal labels 35S
and 32P give the lowest variation in estimated absorbed nuclear dose in our cell model
with defined dimensions (nuclear diameter, 6-16 μm ; cellular diameter, 12-20 μm).
Keywords: Antisense, Dosimetry, Oligonucleotide, Radionanotargeting.
Related Books
Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine
Cancer Metastasis and Cancer Stem Cell/Niche
Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature
Controversies in Neuro-Oncology
Current Advances in Breast Cancer Research: A Molecular Approach
Cutting Edge Therapies for Cancer in the 21st Century
Frontiers in Cancer Immunology
Frontiers in Cancer Immunology
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Frontiers in Clinical Drug Research - Anti-Cancer Agents